160 related articles for article (PubMed ID: 8886045)
21. A phase II study of single-agent gemcitabine as a second-line treatment in advanced non-small cell lung cancer.
Cho KH; Song YB; Choi IS; Cho EH; Choi JW; Ahn YM; Roh YH; Nam SH; Kim BS
Jpn J Clin Oncol; 2006 Jan; 36(1):50-4. PubMed ID: 16418187
[TBL] [Abstract][Full Text] [Related]
22. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study.
Lilenbaum R; Cano R; Schwartz M; Siegel L; Lutzky J; Lewis M; Krill E; Barreras L; Davila E
Cancer; 2000 Feb; 88(3):557-62. PubMed ID: 10649247
[TBL] [Abstract][Full Text] [Related]
24. [A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer].
Ryo H; Toyama K; Isobe K; Sugino K; Sano G; Yamada H; Hiroi M; Hojyo T; Kimura K
Gan To Kagaku Ryoho; 2003 Feb; 30(2):237-42. PubMed ID: 12610872
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
[TBL] [Abstract][Full Text] [Related]
26. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
Tibaldi C; Ricci S; Russo F; Bernardini I; Galli L; Chioni A; Orlandini C; Grosso AM; Pegna AL; Fabbri A; Innocenti F; Ferrari K; Tognarini L; Conte PF; Falcone A;
Lung Cancer; 2005 Apr; 48(1):121-7. PubMed ID: 15777979
[TBL] [Abstract][Full Text] [Related]
27. Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial.
Van Kooten M; Traine G; Cinat G; Cazap E; Comba AZ; Vicente H; Sena S; Nievas OR; Orlando M
Br J Cancer; 1999 Nov; 81(5):846-9. PubMed ID: 10555756
[TBL] [Abstract][Full Text] [Related]
28. [A phase II multicenter study of gemcitabine in non small cell lung cancers].
Le Chevalier T; Gottfried M; Gatzemeier U; Shepherd F; Weynants P; Cottier B; Groen HJ; Rosso R; Mattson K; Cortes-Funes H; Tonato M; Burkes RL; Voi M; Ponzio A
Bull Cancer; 1997 Mar; 84(3):282-8. PubMed ID: 9207875
[TBL] [Abstract][Full Text] [Related]
29. A randomized phase II trial evaluating standard (50 mg/min) versus low (10 mg/min) infusion duration of gemcitabine as first-line treatment in advanced non-small-cell lung cancer patients who are not eligible for platinum-based chemotherapy.
Cappuzzo F; Novello S; De Marinis F; Selvaggi G; Scagliotti GV; Barbieri F; Maur M; Papi M; Pasquini E; Bartolini S; Marini L; Crinò L
Lung Cancer; 2006 Jun; 52(3):319-25. PubMed ID: 16630670
[TBL] [Abstract][Full Text] [Related]
30. Advanced breast cancer: a phase II trial with gemcitabine.
Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer].
Li GZ; Zhang SH; Zhang Z; Wang RL
Ai Zheng; 2007 Dec; 26(12):1377-80. PubMed ID: 18076806
[TBL] [Abstract][Full Text] [Related]
32. Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).
Ferrigno D; Buccheri G;
Lung Cancer; 2004 Sep; 45(3):373-80. PubMed ID: 15301878
[TBL] [Abstract][Full Text] [Related]
33. First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule.
Quoix E; Breton JL; Ducoloné A; Mennecier B; Depierre A; Lemarié E; Moro-Sibilot D; Germa C; Neidhardt AC
Lung Cancer; 2005 Mar; 47(3):405-12. PubMed ID: 15713524
[TBL] [Abstract][Full Text] [Related]
34. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA
Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295
[TBL] [Abstract][Full Text] [Related]
35. Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.
Gatzemeier U; Shepherd FA; Le Chevalier T; Weynants P; Cottier B; Groen HJ; Rosso R; Mattson K; Cortes-Funes H; Tonato M; Burkes RL; Gottfried M; Voi M
Eur J Cancer; 1996 Feb; 32A(2):243-8. PubMed ID: 8664035
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of weekly gemcitabine in advanced non-small cell lung cancer.
Halme M; Jekunen A; Tamminen K; Mattson K
Respir Med; 1997 Aug; 91(7):423-6. PubMed ID: 9327044
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients.
Franciosi V; Barbieri R; Aitini E; Vasini G; Cacciani GC; Capra R; Camisa R; Cascinu S
Lung Cancer; 2003 Jul; 41(1):101-6. PubMed ID: 12826318
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study.
Steward WP; Dunlop DJ; Cameron C; Talbot DC; Kleisbauer JP; Thomas P; Guerin JC; Perol M; Sanson C; Dabouis G
Anticancer Drugs; 1995 Dec; 6 Suppl 6():33-7. PubMed ID: 8718423
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of gemcitabine in advanced non-small-cell lung cancer.
Malayeri R; Ulsperger E; Baumgartner G; Forstner B; Aigner K; Hubner M; Kummer F; Krajnik G; Zöchbauer S; Krejcy K; Huber H; Pirker R
Wien Klin Wochenschr; 1997 Sep; 109(17):688-91. PubMed ID: 9331958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
